p.159 抽出テキスト

pulmonary embolism. Circulation 2000; 102: 211-217. PMID: 10889133 90. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172: 1041-1046. PMID: 16020800 91. Jiménez D, Aujesky D, Moores L, et al. RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170: 1383-1389. PMID: 20696966 92. Righini M, Roy PM, Meyer G, et al. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost 2011; 9: 2115- 2117. PMID: 21848693 93. Mizuno A, Yamamoto T, Tanabe Y, et al. Tokyo CCU Network Scientific Committee. Pulmonary embolism severity index and simplified pulmonary embolism severity index risk scores are useful to predict mortality in Japanese patients with pulmonary embolism. Circ J 2015; 79: 889-891. PMID: 25739720 94. Yamashita Y, Morimoto T, Amano H, et al. Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry. Eur Heart J Acute Cardiovasc Care 2020; 9: 262-270. PMID: 30203659 95. Hull RD, Raskob GE, Brant RF, et al. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med 1997; 157: 2562-2568. PMID: 9531224 96. Kearon C, Ageno W, Cannegieter SC, et al. Subcommittees on control of anticoagulation, and predictive and diagnostic variables in thrombotic disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 2016; 14: 1480-1483. PMID: 27428935 97. Yamashita Y, Morimoto T, Amano H, et al. COMMAND VTE Registry Investigators. Anticoagulation therapy for venous thromboembolism in the real world From the COMMAND VTE Registry. Circ J 2018; 82: 1262-1270. PMID: 29576597 98. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7. PMID: 8644983 99. Eklof B, Perrin M, Delis KT, et al. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg 2009; 49: 498-501. PMID: 19216970 100. Meissner MH. The clinical presentation and natural history of acute deep venous thrombosis. In: Gloviczki P, Dalsing MC, Moneta GL, et al. editors. Handbook of Venous disorders: Guidelines of the American Venous Forum 3rd edn. CRC Press, 2009: 195-220. 101. Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149: 698-707. PMID: 19017588 102. Cheung YW, Middeldorp S, Prins MH, et al. Einstein PTS Investigators Group. Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis. Thromb Haemost 2016; 116: 733- 738. PMID: 27583311 103. Ziegler S, Schillinger M, Maca TH, et al. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res 2001; 101: 23-33. PMID: 11342203 104. de Athayde Soares R, Matielo MF, Brochado Neto FC, et al. Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin. Surgery 2019; 166: 1076-1083. PMID: 31277885 105. Nishimoto Y, Yamashita Y, Morimoto T, et al. COMMAND VTE Registry Investigators. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry. Heart Vessels 2019; 34: 669-677. PMID: 30293163 106. Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program 2010; 2010: 216-220. PMID: 21239797 107. Lefebvre P, Laliberté F, Nutescu EA, et al. All-cause and disease-related health care costs associated with recurrent venous thromboembolism. Thromb Haemost 2013; 110: 1288-1297. PMID: 24085327 108. van Dongen CJ, Prandoni P, Frulla M, et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3: 939-942. PMID: 15869588 109. Chitsike RS, Rodger MA, Kovacs MJ, et al. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. J Thromb Haemost 2012; 10: 2039-2044. PMID: 22846068 110. Kahn SR, Partsch H, Vedantham S, et al. Subcommittee on Control

of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 2009; 7: 879-883. PMID: 19175497 111. Stevinson BG, Hernandez-Nino J, Rose G, et al. Echocardiographic

and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. Eur Heart J 2007; 28: 2517-2524. PMID: 17670755 112. Klok FA, van Kralingen KW, van Dijk AP, et al. Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism. Respir Med 2010; 104: 1744-1749. PMID: 20599368 113. Sista AK, Klok FA. Late outcomes of pulmonary embolism: The post-PE syndrome. Thromb Res 2018; 164: 157-162. PMID: 28641836 114. Humbert M, Kovacs G, Hoeper MM, et al. ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43: 3618- 3731. PMID: 36017548 115. Konstantinides SV, Vicaut E, Danays T, et al. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol 2017; 69: 1536-1544. PMID: 28335835 116. Weitz JI, Lensing AWA, Prins MH, et al. EINSTEIN CHOICE Investigators. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med 2017; 376: 1211-1222. PMID: 28316279 117. Agnelli G, Buller HR, Cohen A, et al. AMPLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med 2013; 368: 699-708. PMID: 23216615 118. Albaghdadi MS, Dudzinski DM, Giordano N, et al. Cardiopulmonary exercise testing in patients following massive and submassive pulmonary embolism. J Am Heart Assoc 2018; 7: e006841. PMID: 29502109 119. Tunariu N, Gibbs SJ, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007; 48: 680-684. PMID: 17475953 120. Pesavento R, Filippi L, Palla A, et al. SCOPE Investigators. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J 2017; 49: 1601980. PMID: 28546279 121. Nakano Y, Adachi S, Nishiyama I, et al. Usefulness of a refined computed tomography imaging method to assess the prevalence of residual pulmonary thrombi in patients 1 year after acute pulmonary embolism: The Nagoya PE study. J Thromb Haemost 2022; 20: 888- 898. PMID: 35000288 122. Fathala A, Aldurabi A. Frequency of computed tomography abnormalities in patients with chronic thromboembolic pulmonary hypertension: a comparative study between lung perfusion scan and computed tomography pulmonary angiography. Multidiscip Respir Med 2021; 16: 753. PMID: 34322231 123. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349: 1227-1235. PMID: 14507948 124. Gibson NS, Sohne M, Kruip MJ, et al. Christopher study investigators. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost 2008; 99: 229- 234. PMID: 18217159 125. Klok FA, Mos IC, Nijkeuter M, et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med 2008; 168: 2131-2136. PMID: 18955643 126. Hendriksen JM, Geersing GJ, Lucassen WA, et al. Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care. BMJ 2015; 351: h4438. PMID: 26349907 127. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83: 416-420. PMID: 10744147 128. Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006; 144: 165-171. PMID: 16461960 129. Jiménez D, Aujesky D, Díaz G, et al. RIETE Investigators. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 2010; 181: 983-991. PMID: 20110556 130. Nakamura M, Miyata T, Ozeki Y, et al. Current venous thromboembolism management and outcomes in Japan. Circ J 2014; 78: 708- 717. PMID: 24401573 131. Sakuma M, Nakamura M, Nakanishi N, et al. Clinical characteris-